Genscript rebounds on HKEX with staunch defense of Legend Biotech's CAR-T data integrity
After a scathing short report triggered a landslide for Genscript’s stock and forced it to halt trading, the company has managed to salvage some of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
